The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part II;Aktualne spojrzenie na zapalne, biochemiczne i hemostatyczne markery oraz czynniki ryzyka choroby niedokrwiennej serca. Cześć II.

Przegla̧d lekarski

Volumn 63, Issue 9, 2006, Pages 767-772

  Rajtar, Renata ^a   Kloch, Małgorzata ^a   Bober, Maria ^a   Kolasińska Kloch, Władysława ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; PLASMINOGEN ACTIVATOR INHIBITOR 1; URIC ACID; VON WILLEBRAND FACTOR;

ANIMAL; ATHEROSCLEROSIS; BIOLOGICAL MODEL; CLINICAL TRIAL; COMORBIDITY; EPIDEMIOLOGY; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNOLOGY; INFECTION; INFLAMMATION; METABOLISM; REVIEW; STANDARD; VASCULITIS;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAUSALITY; CLINICAL TRIALS; COMORBIDITY; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; HYPERHOMOCYSTEINEMIA; INFECTION; INFLAMMATION; MODELS, BIOLOGICAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; URIC ACID; VASCULITIS; VON WILLEBRAND FACTOR;

EID: 34249930878     PISSN: 00332240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)